Delivery Order SPE2DB20D1100-SPE2DB25FB9A1
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract is valued at $9,577.85 under a firm fixed-price arrangement with an ultimate completion date of June 30, 2025. This delivery order is not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods valued at $1,193.52. The contract, which carries a firm fixed price structure and is scheduled for completion by May 5, 2025, represents a non-competitive, non-set-aside award to the prime contractor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,193.52 to AmerisourceBergen Drug Corp on June 3, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitive award, with no set-aside designation, was issued under firm fixed pricing and is scheduled for completion by June 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is supported by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods valued at $4,737.07. The non-competitive delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a small-value transaction for specialized diabetes management medical devices. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $2,444.64 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), 5-supply packages. This competitively awarded, firm fixed price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025. The products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods valued at $1,222.32. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December...
- The Defense Logistics Agency awarded a $2,499.84 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, which became effective on September 10, 2025, with completion targeted for September 11, 2025, utilizes firm fixed pricing with no set-aside designation and was competitively awarded. Performance will be executed from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $9,190.25 to AmerisourceBergen Drug Corp on September 4, 2025, for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The delivery will be fulfilled from the vendor's corporate office in...
- The Defense Logistics Agency awarded a $12,226.93 delivery order (contract 4569778423) to AmerisourceBergen Drug Corp on October 20, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This is a competitively awarded, firm fixed-price contract with no set-aside designation, and performance will be completed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is expected to conclude by October 21, 2025. This award represents a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.09 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods to be performed in Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 5, 2025. As a child order under a larger contract vehicle, this delivery supports the federal government's pharmaceutical and medical supply procurement needs through...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB9A1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods, valued at $2,164.28. This non-competitive delivery order represents a firm fixed-price contract with an ultimate completion date of April 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (Contract SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has established a significant portfolio of competitively awarded contracts with the Defense Logistics Agency Medical Supply Chain. The company's federal contract performance demonstrates extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, and specialized medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for insulin delivery systems reflects AmerisourceBergen's ongoing role as a primary pharmaceutical vendor supporting military and veteran healthcare logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 4/23/25 |